Testing effectiveness (Phase 2)Ended earlyNCT02261883
What this trial is testing
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Who this might be right for
Persistent Pulmonary Hypertension of the Newborn
United Therapeutics 42